isatin has been researched along with Parkinsonian Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buneeva, OA; Kopylov, AT; Medvedev, AE | 1 |
| Buneeva, OA; Kapitsa, IG; Kazieva, LS; Kopylov, AT; Medvedev, AE; Vavilov, NE; Zgoda, VG | 1 |
| Buneeva, OA; Kapitsa, IG; Kazieva, LS; Vavilov, NE; Zgoda, VG | 1 |
| Buneeva, OA; Kapitsa, IG; Medvedev, AE; Zgoda, VG | 1 |
| Buneeva, OA; Kapitsa, IG; Kopylov, AT; Medvedev, AE; Nerobkova, LN; Zgoda, VG | 1 |
| Buneeva, O; Ershov, P; Gnedenko, O; Ivanov, A; Medvedev, A | 1 |
| Hamaue, N; Minami, M; Nagashima, K; Ogata, A; Tashiro, K; Terado, M | 1 |
| Xie, JX; Zhao, ZQ; Zhou, Y | 1 |
1 review(s) available for isatin and Parkinsonian Disorders
| Article | Year |
|---|---|
Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications.
Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Brain; Cell Line; Gene Expression Regulation; Humans; Isatin; Mice; Monoamine Oxidase; Neoplasms, Experimental; Neuroprotective Agents; Parkinsonian Disorders; Rats; Receptors, Atrial Natriuretic Factor; Species Specificity | 2018 |
7 other study(ies) available for isatin and Parkinsonian Disorders
| Article | Year |
|---|---|
[The key role of the regulatory 19S subunit in changes in the brain proteasome subproteome induced by the neuroprotector isatin].
Topics: Animals; Brain; Isatin; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Proteins; Rabbits | 2022 |
[Characteristics of behavioral reactions and the profile of brain isatin-binding proteins of rats with the rotenone-induced experimental parkinsonism].
Topics: Animals; Brain; Carrier Proteins; Isatin; Mice; Neurotoxins; Parkinsonian Disorders; Rats; Rotenone | 2023 |
Quantitative changes of brain isatin-binding proteins of rats with the rotenone-induced experimental parkinsonism.
Topics: Animals; Brain; Carrier Proteins; Humans; Isatin; Neurotoxins; Parkinsonian Disorders; Proteomics; Rats; Rotenone | 2023 |
Neuroprotective effects of isatin and afobazole in rats with rotenone-induced Parkinsonism are accompanied by increased brain levels of Triton X-100 soluble alpha-synuclein.
Topics: alpha-Synuclein; Animals; Brain; Isatin; Neuroprotective Agents; Octoxynol; Parkinsonian Disorders; Proteomics; Rats; Rotenone | 2023 |
[The effect of neurotoxin MPTP administration to mice on the proteomic profile of brain isatin-binding proteins].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Carrier Proteins; Disease Models, Animal; Isatin; Locomotion; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Proteome | 2017 |
Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Topics: Animals; Brain; Disease Models, Animal; Encephalitis Virus, Japanese; Hypokinesia; Isatin; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Rats; Rats, Inbred F344; Tyrosine 3-Monooxygenase | 2003 |
Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats.
Topics: Animals; Apomorphine; Behavior, Animal; Biogenic Monoamines; Caudate Nucleus; Dopamine; Female; Isatin; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinsonian Disorders; Putamen; Rats; Rats, Wistar; Reference Values; Rotation; Stereotyped Behavior | 2001 |